![](/img/cover-not-exists.png)
493 Preclinical pharmacokinetic (PK)/pharmacodynamic (PD)/Efficacy modeling for MLN2480, an investigational pan-RAF kinase inhibitor, in A375 and SKMEL-2 human melanoma xenografts
Patel, M., Chouitar, J., Mettetal, J., Gangolli, E., Balani, S., Shimoga, P., Galvin, K., Shyu, W.C., Chakravarty, A., Zopf, C.J.Volume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(14)70619-7
Date:
November, 2014
File:
PDF, 58 KB
english, 2014